OFI Invest Asset Management Takes $6.67 Million Position in The Clorox Company $CLX

Key Points

• OFI Invest Asset Management purchased a new stake of 66,102 shares in The Clorox Company valued at about $6.67 million in the fourth quarter, representing roughly 0.05% ownership per its latest 13F filing.
• Clorox declared a quarterly dividend of $1.24 (annualized $4.96), yielding 4.6% with an ex-dividend date of April 22 and payment on May 8.
• Recent results were mixed—Clorox reported $1.39 EPS (missed by $0.04) on $1.67B revenue (down 0.8% YoY)—and analyst sentiment is cautious, with an average MarketBeat rating of "Reduce" and a consensus price target of $115.93 after several downgrades.

OFI Invest Asset Management purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 66,102 shares of the company's stock, valued at approximately $6,665,000. OFI Invest Asset Management owned approximately 0.05% of Clorox as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in CLX. Van ECK Associates Corp increased its position in shares of Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company's stock valued at $334,139,000 after buying an additional 1,312,471 shares in the last quarter. Invesco Ltd. increased its position in shares of Clorox by 23.1% in the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company's stock valued at $492,656,000 after buying an additional 750,415 shares in the last quarter. Worldquant Millennium Advisors LLC purchased a new position in shares of Clorox in the second quarter valued at $71,856,000. VIRGINIA RETIREMENT SYSTEMS ET Al increased its position in shares of Clorox by 24,944.4% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 450,800 shares of the company's stock valued at $55,584,000 after buying an additional 449,000 shares in the last quarter. Finally, Two Sigma Investments LP increased its position in shares of Clorox by 33.8% in the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company's stock valued at $214,564,000 after buying an additional 439,797 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Trading Up 1.9%

Clorox stock opened at $107.72 on Friday. The stock has a market cap of $13.02 billion, a PE ratio of 17.60, a P/E/G ratio of 0.52 and a beta of 0.65. The stock has a 50-day moving average price of $114.31 and a 200 day moving average price of $111.05. The Clorox Company has a 52 week low of $96.66 and a 52 week high of $143.96. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm's quarterly revenue was down .8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.55 EPS. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be issued a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 4.6%. Clorox's payout ratio is 81.05%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CLX. Weiss Ratings cut Clorox from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, March 27th. Rothschild & Co Redburn set a $117.00 price objective on Clorox in a research report on Friday, February 13th. The Goldman Sachs Group dropped their price objective on Clorox from $110.00 to $94.00 and set a "sell" rating for the company in a research report on Wednesday, January 7th. Evercore dropped their price objective on Clorox from $132.00 to $115.00 and set an "underperform" rating for the company in a research report on Wednesday, February 4th. Finally, Morgan Stanley lifted their price objective on Clorox from $125.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Reduce" and an average price target of $115.93.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Hidden Valley product innovation and digital initiatives are being highlighted as drivers of growth and improved operational resilience, supporting revenue diversification and brand momentum. Clorox's Hidden Valley Ranch Fuels Innovation With New Flavor Lineup
• Positive Sentiment: Coverage noting that Clorox is strengthening its position in the consumer staples segment, a potential tailwind for steady demand and dividend support. Clorox NYSE: CLX Strengthens Position In Consumer Staples Segment
• Neutral Sentiment: Clorox will release third‑quarter fiscal 2026 results and host a webcast on April 30 — a scheduled event that increases the probability of short‑term volatility and will likely reset guidance/consensus reactions. Clorox Announces April 30 Webcast of Third-Quarter Fiscal Year 2026 Results
• Neutral Sentiment: Broader dividend-stock coverage briefly references Clorox among stable income names, which underscores its defensive appeal but is unlikely to move the stock materially near term. 3 ASX Dividend Stocks To Consider With Up To 5.5% Yield
• Negative Sentiment: Wells Fargo cut its price target to $110 (from $125) and kept an Equal Weight rating, citing inflationary pressure on margins and trimming sector estimates ahead of earnings — a bearish catalyst that can cap near‑term upside. Wells Fargo Cuts Clorox (CLX) Price Target, Sees Inflation Pressuring Margins
• Negative Sentiment: Royal Bank of Canada trimmed its price target to $127 from $132 and maintained a Sector Perform rating — another analyst move that reduces consensus upside and signals caution. RBC Lowers Price Target on Clorox to $127 From $132; Keeps Sector Perform Rating
• Negative Sentiment: UBS has lowered expectations for CLX, adding to analyst pressure ahead of the earnings print and reinforcing investor focus on margins and volume trends. UBS Group Has Lowered Expectations for Clorox NYSE: CLX Stock Price

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.